Cimerli: payments to doctors
Payments that named Cimerli as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $747K
- Providers
- 1,317
- Transactions
- 3,889
- Average per transaction
- $192
The per-transaction average — $192 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,317 providers the average total is $568, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Coherus Biosciences Inc. | $665,223 | 89.0% |
| Sandoz | $82,253 | 11.0% |